{"id":51623,"date":"2023-05-22T13:38:34","date_gmt":"2023-05-22T11:38:34","guid":{"rendered":"https:\/\/haei.org\/?p=51623"},"modified":"2023-05-27T13:39:14","modified_gmt":"2023-05-27T11:39:14","slug":"orladeyo-granted-marketing-authorization-in-chile","status":"publish","type":"post","link":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/","title":{"rendered":"ORLADEYO\u00ae granted marketing authorization in Chile"},"content":{"rendered":"<p>The Public Health Institute (ISP) of Chile has granted marketing authorization for oral, once-daily ORLADEYO\u00ae (berotralstat) for the prophylaxis of HAE attacks in patients 12 years of age or older.<\/p>\n<p>\u201cThe announcement marks the first approval of ORLADEYO in Latin America, which is an important step forward in addressing the significant unmet needs of HAE patients who live in the region. With this approval, we continue our mission to bring ORLADEYO to patients around the world who could benefit from an oral, once-daily prophylactic treatment option to improve control of their HAE attacks,\u201d says Charlie Gayer, Chief Commercial Officer of <strong>BioCryst Pharmaceuticals, Inc.<br \/>\n<\/strong><br \/>\nBioCryst has an exclusive collaboration with Pint Pharma GmbH to register and promote ORLADEYO in the pan-Latin America region. Under the terms of the agreement, Pint is responsible for obtaining and maintaining all marketing authorizations and for commercializing ORLADEYO in the region.<br \/>\n<em>(Source: BioCryst)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Public Health Institute (ISP) of Chile has granted marketing authorization for oral, once-daily ORLADEYO\u00ae (berotralstat) for the prophylaxis of HAE attacks in patients 12 years of age or older. \u201cThe announcement marks the first approval of ORLADEYO in Latin America, which is an important step forward in addressing the significant unmet needs of HAE [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":40709,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ORLADEYO\u00ae granted marketing authorization in Chile - HAE International (HAEi)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ORLADEYO\u00ae granted marketing authorization in Chile - HAE International (HAEi)\" \/>\n<meta property=\"og:description\" content=\"The Public Health Institute (ISP) of Chile has granted marketing authorization for oral, once-daily ORLADEYO\u00ae (berotralstat) for the prophylaxis of HAE attacks in patients 12 years of age or older. \u201cThe announcement marks the first approval of ORLADEYO in Latin America, which is an important step forward in addressing the significant unmet needs of HAE [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\" \/>\n<meta property=\"og:site_name\" content=\"HAE International (HAEi)\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/haeinternational\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-22T11:38:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-27T11:39:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"765\" \/>\n\t<meta property=\"og:image:height\" content=\"565\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"PlusR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@haeday\" \/>\n<meta name=\"twitter:site\" content=\"@haeday\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"PlusR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\"},\"author\":{\"name\":\"PlusR\",\"@id\":\"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044\"},\"headline\":\"ORLADEYO\u00ae granted marketing authorization in Chile\",\"datePublished\":\"2023-05-22T11:38:34+00:00\",\"dateModified\":\"2023-05-27T11:39:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\"},\"wordCount\":152,\"publisher\":{\"@id\":\"https:\/\/haei.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"articleSection\":[\"HAEi News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\",\"url\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\",\"name\":\"ORLADEYO\u00ae granted marketing authorization in Chile - HAE International (HAEi)\",\"isPartOf\":{\"@id\":\"https:\/\/haei.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"datePublished\":\"2023-05-22T11:38:34+00:00\",\"dateModified\":\"2023-05-27T11:39:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage\",\"url\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"contentUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"width\":765,\"height\":565},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/haei.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ORLADEYO\u00ae granted marketing authorization in Chile\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haei.org\/#website\",\"url\":\"https:\/\/haei.org\/\",\"name\":\"HAE International (HAEi)\",\"description\":\"HAE International (HAEi) is the global umbrella organization for the world\u2019s Hereditary Angioedema (HAE) patient groups.\",\"publisher\":{\"@id\":\"https:\/\/haei.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haei.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/haei.org\/#organization\",\"name\":\"HAE International\",\"url\":\"https:\/\/haei.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haei.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png\",\"contentUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png\",\"width\":162,\"height\":82,\"caption\":\"HAE International\"},\"image\":{\"@id\":\"https:\/\/haei.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/haeinternational\/\",\"https:\/\/x.com\/haeday\",\"https:\/\/www.linkedin.com\/company\/haei---international-patient-organization-for-c1-inhibitor-deficiencies\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044\",\"name\":\"PlusR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haei.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g\",\"caption\":\"PlusR\"},\"url\":\"https:\/\/haei.org\/author\/rikke\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ORLADEYO\u00ae granted marketing authorization in Chile - HAE International (HAEi)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/","og_locale":"en_US","og_type":"article","og_title":"ORLADEYO\u00ae granted marketing authorization in Chile - HAE International (HAEi)","og_description":"The Public Health Institute (ISP) of Chile has granted marketing authorization for oral, once-daily ORLADEYO\u00ae (berotralstat) for the prophylaxis of HAE attacks in patients 12 years of age or older. \u201cThe announcement marks the first approval of ORLADEYO in Latin America, which is an important step forward in addressing the significant unmet needs of HAE [&hellip;]","og_url":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/","og_site_name":"HAE International (HAEi)","article_publisher":"https:\/\/www.facebook.com\/haeinternational\/","article_published_time":"2023-05-22T11:38:34+00:00","article_modified_time":"2023-05-27T11:39:14+00:00","og_image":[{"width":765,"height":565,"url":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","type":"image\/jpeg"}],"author":"PlusR","twitter_card":"summary_large_image","twitter_creator":"@haeday","twitter_site":"@haeday","twitter_misc":{"Written by":"PlusR","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#article","isPartOf":{"@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/"},"author":{"name":"PlusR","@id":"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044"},"headline":"ORLADEYO\u00ae granted marketing authorization in Chile","datePublished":"2023-05-22T11:38:34+00:00","dateModified":"2023-05-27T11:39:14+00:00","mainEntityOfPage":{"@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/"},"wordCount":152,"publisher":{"@id":"https:\/\/haei.org\/#organization"},"image":{"@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage"},"thumbnailUrl":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","articleSection":["HAEi News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/","url":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/","name":"ORLADEYO\u00ae granted marketing authorization in Chile - HAE International (HAEi)","isPartOf":{"@id":"https:\/\/haei.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage"},"image":{"@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage"},"thumbnailUrl":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","datePublished":"2023-05-22T11:38:34+00:00","dateModified":"2023-05-27T11:39:14+00:00","breadcrumb":{"@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#primaryimage","url":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","contentUrl":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","width":765,"height":565},{"@type":"BreadcrumbList","@id":"https:\/\/haei.org\/orladeyo-granted-marketing-authorization-in-chile\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/haei.org\/"},{"@type":"ListItem","position":2,"name":"ORLADEYO\u00ae granted marketing authorization in Chile"}]},{"@type":"WebSite","@id":"https:\/\/haei.org\/#website","url":"https:\/\/haei.org\/","name":"HAE International (HAEi)","description":"HAE International (HAEi) is the global umbrella organization for the world\u2019s Hereditary Angioedema (HAE) patient groups.","publisher":{"@id":"https:\/\/haei.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haei.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/haei.org\/#organization","name":"HAE International","url":"https:\/\/haei.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haei.org\/#\/schema\/logo\/image\/","url":"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png","contentUrl":"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png","width":162,"height":82,"caption":"HAE International"},"image":{"@id":"https:\/\/haei.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/haeinternational\/","https:\/\/x.com\/haeday","https:\/\/www.linkedin.com\/company\/haei---international-patient-organization-for-c1-inhibitor-deficiencies\/"]},{"@type":"Person","@id":"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044","name":"PlusR","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haei.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g","caption":"PlusR"},"url":"https:\/\/haei.org\/author\/rikke\/"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"HAE International (HAEi)","distributor_original_site_url":"https:\/\/haei.org","push-errors":false,"_links":{"self":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts\/51623"}],"collection":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/comments?post=51623"}],"version-history":[{"count":1,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts\/51623\/revisions"}],"predecessor-version":[{"id":51624,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts\/51623\/revisions\/51624"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/media\/40709"}],"wp:attachment":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/media?parent=51623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/categories?post=51623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/tags?post=51623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}